Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All Resources
Filters
Select resource types
Select products & services (1)
Select solutions
Active Filters (1)
Clear All
1 - 12 of 249 Results
Sort by:
Best Match
Whitepaper
Get our White Paper about autoimmunity
A complete review on current and emerging therapeutic approaches for autoimmune diseases
Infographic
Cell cycle infographic
Targeting various steps of the cell cycle is a promising strategy for cancer therapeutics. Learn more from our infographic.
Literature - Publication Review
Research and characterization of bispecific antibodies for cancer immunotherapies
In this literature review, we describe several functional approaches to characterize novel BsAbs targeting immune checkpoints and the tumor necrosis factor (TNF) superfamily, with easy-to-use immunoassays.
Whitepaper
Chimeric Antigen Receptor (CAR) Natural Killer cells: a promising cell therapy strategy for cancer treatment
Featured in this white paper is information on NK cells and cytotoxicity, CAR NK cell therapy description, including genetic modification and CAR generation, and advantages, limitations, and clinical progress of CAR NK cell therapy.
Infographic
Protein recycling, TPD, and neurodegenerative disease
Targeted protein degradation (TPD) via the proteasomal and lysosomal pathways is a promising therapeutic approach that represents a novel tool for exploring cellular pathways. TPD offers several key advantages over traditional occupancy-based inhibitors, notably concerning dosing, drug resistance, and side effects.
Guide
The Gene Therapy Industry: A Brief Report
Gene therapy industry report: A growing market, current challenges, and an exciting future.
Application Note
Developing novel tetraubiquitin substrates and AlphaLISA technology to provide next generation deubiquitinase assays
This application note presents novel biochemical DUB assays that use TUBEs to bind to tetraubiquitin substrates of at least three natural linkages. These assays, combined with Revvity’s AlphaLISA™ technology, allow for the measurement of protein interactions and large protein complexes in a no-wash, homogeneous assay.
Literature - Publication Review
Literature review on protein-protein interaction assays for virology research
This literature review reviews recent publications and show the homogeneous assay set-ups used in a variety of different studies. We present the outcomes of each study and how the information gathered could lead to antiviral therapies.
Whitepaper
Download your white paper on data analysis methods
This white paper gives you tools for analyzing obtained experimental data such as 2nd messenger quantification for GPCR investigation and screening.
Literature - Publication Review
Novel drugs for cancer therapy development with PROTAC
A review of current homogeneous assay applications for PROTACs
Literature - Publication Review
Novel drugs for cancer therapy development with PROTAC
A review of current homogeneous assay applications for PROTACs
Application Note
Detection of human matrix metalloproteinase 9 in complex sample matrices, a comparison of AlphaLISA and colorimetric ELISA immunoassays
This note compares two immunoassay technologies: ELISA (enzyme-linked immunosorbent assay) and AlphaLISA™ (amplified luminescent proximity-based homogeneous assay).
Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.